Thursday, January 29, 2009 11:03:05 AM
Personalized Medicine on Friday's Mad Money...
http://www.cnbc.com/id/28813740
Excerpt: "Personalized medicine uses everything from height and weight to gene and gene-expression information to treat patients. Celera and Abbott are trying to develop molecular diagnostic products to aid in the process. The two firms recently updated their deal, which should lower Celera’s operating expenses and give the company room to launch products outside the joint venture with Abbott. So even if a merger never happens, Celera might stand on its own as a solid investment."
More here:
http://www.madmoneyrecap.com/madmoney_nightlyrecap_012309_2.htm
Excerpt: "... personalized medicine requires a lot of diagnostic tests... and that is what Celera is working on with Abbott Labs... disease detection, assessing an individuals pre-disposition to certain diseases... monitoring the progression of a disease… and choosing the right therapy…. remember President Obama loves this stuff... because it saves money on health care costs down the line..."
http://www.dnaprint.com/welcome/corporate/
http://www.dnaprint.com/welcome/pipeline/
Daniel
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM